Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma

Sarcoma

Volumn 7, Issue 1, 2003, Pages 1-7

  Simon, James H ^a   Paulino, Arnold C ^a,c   Ritchie, Justine M ^b   Mayr, Nina A ^a   Buatti, John M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c EMORY CLINIC   (United States)

Author keywords

Adults; Extremity; Radiotherapy; Rhabdomyosarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINCRISTINE;

ADOLESCENT; ADULT; CANCER CLASSIFICATION; CANCER CONTROL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LIMB TUMOR; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL CANCER; RHABDOMYOSARCOMA; SEX DIFFERENCE; TUMOR LOCALIZATION; UROGENITAL TRACT CANCER;

EID: 0038293011     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1357714031000114147     Document Type: Conference Paper

References (12)

1. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-3102.
2. Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DH, Gold JS, Woodruff JM, Lewis JJ, Brennan MF. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 2001; 91:794-803.
3. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Ant Star Assoc 1958; 53: 457-81.
4. Cox DR. Regression models and life tables (with discussion). J R Star Soc B 1972; 34: 187-220.
5. SAS System for Windows. Version 8.0, 1999. Cary, NC: SAS Institute, Inc.
6. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol 1993; 17: 601-609.
7. Tallini G, Parham DM, Dias P, Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol 1994; 144: 693-701.
8. Wesche WA, Fletcher CD, Dias P, Houghton PJ, Patham DM. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995; 19: 261-9.
9. Esnaola NF, Rubin BP, Baldini EH, Vasudevan N, Demetri GD, Fletcher CD, Singer S. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg 2001; 234: 215-23.
10. Prestidge BR, Donaldson SS. Treatment results among adults with childhood tumors: a 20-year experience. Int J Radiat Oncol Biol Phys 1989; 17: 507-14.
11. Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD Jr, Wiener ES, Qualman SJ, Donaldson SS. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 1999; 17: 3468-75.
12. Czyzewski EAD, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue: a feasibility study. Int J Radiat Oncol Biol Phys 1999; 44: 569-77.